Change of President and CEO at Carl Zeiss Meditec AG The President and CEO, Dr. Markus Weber, will step down from the Management Board, of his own accord and on the best of terms, on 31 May 2025. Starting 1 June 2025, the new President and CEO will be Maximilian Foerst, who is currently Head of ZEISS Greater China. Jena, Germany | 7 May 2025 | C [ … ]

Change of President and CEO at Carl Zeiss Meditec AG   Jena, May 7, 2025 The supervisory board of Carl Zeiss Meditec AG (ISIN: DE0005313704) in today’s meeting has agreed on a change in the Management Board of the company. Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG since January 1, 2022, will turn over his position to Maxi [ … ]

Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25   Jena, April 15, 2025 In the second quarter of fiscal year 2024/25 ending March 31, 2025, Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of around EUR 560 million (previous year: EUR 472.1 million), based on preliminary data, an increase of around 19%. [ … ]

ZEISS VISUMAX 800 with SMILE pro software receives approval in China   Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow enhancements.   JENA,(Germany), SHANGHAI, (China), | 27 February 2025 | Carl Zeiss Meditec AG ZEISS Medical Technology announced to [ … ]

Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25  Significant recovery in order entry and order backlog   JENA, 12 February 2025 Carl Zeiss Meditec generated revenue of €490.5m in the first three months of fiscal year 2024/25 (prior year: €475.0m), corresponding to growth of +3.2% (adjusted for currency effec [ … ]